Omeros Corporation (OMER) financial statements and ratios from SEC XBRL: revenue $2.30M (latest fiscal year), net margin -145.7%, revenue growth 1313.3% YoY, P/E 131.3. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (latest FY) | $2.30M |
| Net Margin | -145.7% |
| Net Debt / EBITDA | -2.1 |
| Revenue Growth (YoY) | 1313.3% |
| EPS Growth (YoY) | -234.5% |
| FCF Growth (YoY) | -59.6% |
| P/E Ratio | 131.3 |
| Price / Sales | 34.93 |
| FCF Yield | -8.5% |
| Altman Z-Score | -2.85 (distress) |
| Industry P/E (Pharmaceutical Products) | 17.2 |
| Sector P/E (Healthcare) | 21.6 |
OMER overview · OMER earnings · OMER KPIs · OMER documents · OMER ownership · OMER peers
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.